What makes FXI inhibition different from current approaches to thrombosis prevention?
Session:
How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention
Topic:
Atrial Fibrillation (AF)
Speaker:
Professor V. Caso (Perugia, IT)
Sponsored by Bayer AG
Event:
ESC Congress 2022
Congress Presentation
About the speaker
Professor Valeria Caso
Hospital Santa Maria Della Misericordia, Perugia (Italy)
5
presentations
2
followers
3 more presentations in this session
Which patients will benefit most from FXI inhibition?
Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Access the full session
How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention
Speakers:
Professor V. Caso, Doctor M. Patel, Professor V. Kunadian
About the event
ESC 365 is supported by
